Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8135581 | 8404931 | I | 8135581-8 | 20110501 | 20120206 | 20120214 | EXP | PHHY2011CA33840 | NOVARTIS PHARMACEUTICAL CORPORATION | 92 | YR | F | Y | 20120214 | CN | CANADA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
8135581 | 1018857261 | SS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | 5 MG, UNK | 021817 | ||||
8135581 | 1018857260 | SS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | 5 MG, UNK | 021817 | ||||
8135581 | 1018857259 | PS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | 5 MG, UNK | 021817 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
8135581 | 1018857259 | OSTEOPOROSIS |
Outcome of event
Event ID | OUTC COD |
---|---|
8135581 | OT |
Reactions reported
Event ID | PT |
---|---|
8135581 | FALL |
8135581 | UPPER LIMB FRACTURE |
8135581 | VENOUS OCCLUSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
8135581 | 1018857261 | 20110502 | |||
8135581 | 1018857260 | 20100325 | |||
8135581 | 1018857259 | 20090128 |